Company news

Little Green Pharma Ltd. (ASX:LGP) news

Little Green Pharma Ltd. news releases on 6ix. Latest, Nov 2, 2022: LGP announces $4 million placement and $2 million SPP

View Little Green Pharma Ltd. →

Press releases — page 2

LGP announces $4 million placement and $2 million SPP

November 1, 2022

Exclusive supply agreement with Cannamedical in Germany

October 3, 2022

TGA advertising infringement notices

September 27, 2022

Little Green Pharma : Quarterly Activities Report & Appendix 4C

July 26, 2022

Little Green Pharma : Application for quotation of securities - LGP

July 20, 2022

LGP signs $2M supply agreement with Ilios Sante

July 11, 2022

Little Green Pharma : Company Update Presentation

June 5, 2022

Exclusive supply contract for new high-THC strain in Germany

May 18, 2022

LGP Signs Key UK Supply Agreement

May 1, 2022

LGP Denmark Signs Major Sales Agreement with Demecan

April 18, 2022

LGP Wins Italian Tender

February 17, 2022

Intention to Demerge Psychedelics Business

February 7, 2022

Exclusive Distribution Agreement for LGP Medicines in Greece

January 20, 2022

Exclusive Cannabis Oils Distribution Agreement in Germany

January 18, 2022

First Registration for Produced Cannabis Medicine in Denmark

November 22, 2021

LGP expands into Psychedelic Medicines

September 6, 2021

First Danish Shipment to Australia, Key Appointments

September 5, 2021

LGP acquires Denmark facility and undertakes share placement

June 22, 2021

Investor Presentation - Denmark acquisition & capital raise

June 22, 2021

Exclusive distribution partner - leading Polish pharma group

June 17, 2021

Update to Sales and Distribution in Australia and Germany

June 14, 2021

$2.5m firm order increases expected DEMECAN revenue to $5.7m

May 26, 2021

LGP agrees Danish Distribution Agreement with Balancial

April 19, 2021

Firm purchase order from Demecan and acquisition of land

March 14, 2021

Share Purchase Plan Offer Booklet

February 14, 2021

LGP secures firm commitments to raise $22 million

February 8, 2021

LGP exports first commercial shipment to Germany

February 5, 2021

LGP wins French government tender

January 26, 2021

TGA announces final CBD down-scheduling decision

December 15, 2020

First Australian Medicinal Cannabis Oils Exported to Germany

November 18, 2020

LGP enters strategic partnership with HIF

November 10, 2020

Pause in Trading

November 9, 2020

Little Green Pharma granted GMP Licence

October 13, 2020

TGA Medicinal Cannabis Post Market Survey

September 22, 2020

Annual Report to shareholders

August 31, 2020

Medicinal Cannabis Permit Granted for Expanded Facility

July 19, 2020

Strategic Shipment Exported to the UK

June 28, 2020

Sales Update - April 2020

May 27, 2020

Clarification Statement

May 13, 2020

ODC Manufacturing Permit Granted

May 10, 2020

Investor Presentation

April 29, 2020

First UK Shipment of Australian Medicinal Cannabis Oil

April 14, 2020

COVID-19 Business Update

April 1, 2020

Commissioning of Cultivation Facility Expansion Complete

March 25, 2020

Expanded Medicinal Licence and new Manufacturing Licence

March 11, 2020

Fourth Medicinal Cannabis Oil Product

March 1, 2020

Appendix 4D and Half Yearly Report

February 27, 2020

German Purchase Agreement with Demecan

February 26, 2020

← Newer